Comparing PET/MR and MRI scans for finding liver cancer
Part of Cancer, Digestive system clinical trials.
This study compares two advanced imaging tests — PET/CT and enhanced MRI — to see which one finds liver cancers or spread to the liver more accurately. If you join, you'll get one or both of these scans, which may help your doctor spot issues earlier and plan your care better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a suspected liver lesion or possible spread of cancer to the liver (based on symptoms or blood tests).
- You must be able to undergo a combined PET/MR scan (a type of detailed imaging test).
- You should not be allergic to MRI contrast dye.
- You cannot be pregnant or breastfeeding.
- You must not have severe heart, kidney, or liver failure that would make the scan unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combined PET/MRI scan can better find and see liver tumors or cancer that has spread to the liver. If you are eligible, you will get this special imaging test, which may help doctors diagnose and plan your treatment more accurately.
This study compares different scan types (MRI, CT, and two PET scans) in people with hepatocellular carcinoma (a primary liver cancer). It may help doctors figure out which scan gives the most useful information for diagnosis and treatment planning.
This study looks at how well special imaging scans (PET/CT or PET/MRI) work in adults with suspected or diagnosed liver cancer. It may help doctors better see the cancer and plan next steps.
This trial tests whether a new PET imaging agent (GPC3-targeted) can find liver cancer as well as or better than enhanced MRI. It may help diagnose hepatocellular carcinoma (the most common type of liver cancer) more accurately.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
This study looks at images from two types of scans (a PET/CT and an MRI) taken of people with stomach cancer. It aims to see how well these scans work together to show the cancer, which could guide better treatment planning.
Hear when a new Hepatoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.